BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33417954
Number of visits today
3784
Number of downloads
16607577
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: López-Sánchez LM, Mena R, Guil-Luna S, Mantrana A, Peñarando J, Toledano-Fonseca M, Conde F, De la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A. Nitric oxide-targeted therapy inhibits stemness and increases the efficacy of tamoxifen in estrogen receptor-positive breast cancer cells. Lab Invest 2021;101:292-303. [PMID: 33262438 DOI: 10.1038/s41374-020-00507-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li Y, Yoon B, Dey A, Nguyen VQ, Park JH. Recent progress in nitric oxide-generating nanomedicine for cancer therapy. J Control Release 2022;352:179-98. [PMID: 36228954 DOI: 10.1016/j.jconrel.2022.10.012] [Reference Citation Analysis]
2 Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M, Bonavida B. The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis. Antioxidants (Basel) 2022;11:1195. [PMID: 35740092 DOI: 10.3390/antiox11061195] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hu X, Gao X, Gao G, Wang Y, Cao H, Li D, Hua H. Discovery of β-carboline-(phenylsulfonyl)furoxan hybrids as potential anti-breast cancer agents. Bioorganic & Medicinal Chemistry Letters 2021;40:127952. [DOI: 10.1016/j.bmcl.2021.127952] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345